Abstract
Sufficient hemostasis during oral surgical procedures is crucial for successful outcomes, can play a key role in establishing hemostasis and to reduce healthcare resource utilization. The search for a topical hemostatic drug that gives the desired effects has led to the need to develop a new substance based on a chemical compound with excellent hemostatic properties. This study is aimed at experimental and clinical evaluation of effectiveness as a topical hemostatic Caprofer and their impact on ease of operation in clinical dental practice. Based on the obtained clinical and experimental material, it is possible to come to an objectively justified conclusion about the high therapeutic efficacy topical hemostatic Caprofer which allows its widespread use as a therapeutic and prophylactic agent for bleeding and inflammation of the maxillofacial region. Caprofer, which has a hemostatic action, is used as in prophylactic, as well as in medical purposes in case of post-surgical bleeding in the oral cavity, creates favorable conditions for wound healing characteristics, characterized by a pronounced advantage over hemostatic amy analogous local action, expressed in instantly developing hemo static effect after its application to a bleeding wound. Along with distinct hemostatic characteristics, there were so, that the caprofer favorably differs and its high antimicrobial, antioxidant and anti-inflammatory action. Based on сlinical-experimental studies, we present the possibility of confirm these properties of the drug.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
